ACR 2022 Tweet by Dr. Rachel Tate

A focused discussion on updates in spondyloarthritis, including emerging data, treatment strategies, and real-world care considerations. Hear expert perspectives and practical takeaways shaping SpA management today.

Obesity in axial spondyloarthritis (axSpA) is not a minor comorbidity. Beyond the scale, there are several factors that need to be considered with obesity in axSpA.

Replay of RheumNow Live 2025 - Spondyloarthritis Sponsored by AbbVie Featuring: Dr. Desiree van der Heidje - Advances in Treatment of Spondyloarthritis Dr. Jennifer Cather - Progress in Hidradenitis Supprativa Dr. Catherine Bakewell - Imaging Evaluation of Spondyloarthritis